From UFC.com – After finding self, Perez helps others in retirement

Article taken from UFC.com.

It’s about living your life how you want to live it.


Last August in Saskatoon, a 54-second knockout of veteran Sam Stout by a young and fairly unknown lightweight prospect named Frankie Perez culminated with an impromptu retirement inside the Octagon.


To everyone’s surprise, including his coaches and father, it was the 26-year-old from Howell, New Jersey – who had just won his first UFC bout – hanging up his four-ounce gloves.


It wasn’t an easy decision for Perez, but it was his call to make and to live with and, ultimately, he was happy with it.

“It was just something that felt right,” he said. “I never second guessed myself. I’ve been doing this since I was 17 years old. I never lived a normal lifestyle but I don’t regret the life I lived. I loved the fighting and the training, but I just came to grips with it that it was time to live my life the way I wanted to live it.”


Besides improving his record to 10-2, Perez took home a Performance of the Night bonus for less than a minute’s work. The outcome was a complete 180 from what he experienced seven months earlier in his UFC debut against Johnny Case. That January night in Boston, Perez felt like a shell of himself and, in the end, was finished for the first time in his pro career. The seeds of Perez’s eventual retirement on a high note were truly sewn from those low moments earlier in the year.


“Going into that first UFC fight, it was the worst of all situations,” Perez said. “I lost two family members back-to-back and I got TKO’ed. I hit rock bottom. Going into the camp against Sam, I thought there’s nothing that could happen to make it worse. It was a clean slate for me. There was nobody that could have been in front of me that day that was going to beat me.”


Win or lose against Stout, Perez was planning on walking away, as he told his mom, his brother, his two sisters and his best friend over the phone from his hotel room in Saskatoon after completing his final weight cut. Since then, Perez followed through on that promise to himself as he took a much needed break from the life of a full-time fighter. Instead of battling guys like Edson Barboza and former UFC lightweight champion Frankie Edgar in the gym six days a week, Perez traveled, had some fun, ate too much and got to spend time with his family.


While on this sabbatical of sorts, Perez came to peace with himself and the sport and remembered why he loved it. Recently, Perez has started training full-time again with the famed New Jersey team overseen by Mark Henry and Ricardo Almeida, and right now, his focus is helping others.


Professionally, Perez is Corey Anderson’s Muay Thai coach, was Barboza’s main sparring partner ahead of his UFC 197 win against Anthony Pettis and is teaching MMA classes at Nick Catone’s gym in Bricktown. Personally, Perez has become involved with a different fight – one against muscular dystrophy with Jim Raffone and his charity, JAR of Hope.


“Jim’s son was diagnosed with Duchenne muscular dystrophy, which is the rarest and most aggressive form,” Perez said. “And there’s no cure. Jim had been trying to get a hold of me to train him to fight. He really wants to do an exhibition fight to raise money for his son and this research that he’s investing in. We finally sat down and he laid everything out for me and I couldn’t say no. His son is basically dying in front of him and he’s trying anything he can to save him.”


Over the past year, Raffone and his seven-year-old son Jamesy have become celebrities in Monmouth County. Through JAR of Hope, Raffone, a father of three, has raised over $240,000 for research into the Duchenne muscular dystrophy that afflicts his son. Once a bodybuilder and personal trainer, he is doing everything he can think of to raise money to help combat his son’s degenerative disease and hopefully find a cure, from competing in push-up contests and running marathons to training for an amateur MMA fight.


Click here to learn more about JAR of Hope, or follow them on Twitter @JAR_of_Hope

"I’d like to thank the UFC for giving me the opportunity to put me on a bit of a pedestal to get my name out there and help organizations like (JAR of Hope) and bring some traffic their way." -- Frankie Perez

“He’s an incredible individual,” Perez said. “He’s not a young guy, but he is athletic. He runs these marathons like it’s nothing and goes back to work the next day. He doesn’t have any quit in him. I call him the ‘2016 John Q.’ He’s just an average guy who is willing to do anything to save his son. If helping him get ready for an amateur MMA fight is what he wants from me, then let’s do it.”


Their sights are set on an October debut for Raffone, and Perez has also enlisted fellow UFC veteran Dante Rivera – who is Raffone’s BJJ coach – to aid the cause.


“We’re giving Jim as much time as we can to raise as much money as we can to save his son’s life through JAR of Hope. I’d like to thank the UFC for giving me the opportunity to put me on a bit of a pedestal to get my name out there and help organizations like Jim’s and bring some traffic their way.”


Along with JAR of Hope, Perez is taking a cue from Raffone and he plans to raise money through his family’s Dead Serious MMA Promotion for multiple sclerosis research, as Perez's sister suffers from the disease. And on June 11, Perez will be lacing up a different type of gloves, as he will compete in a kickboxing bout as the main event for World Class Kickboxing Championships in North Bergen to raise money for JAR of Hope and the National Multiple Sclerosis Society.


In retirement, Frankie Perez's life is as physically demanding as ever. But with a renewed focus on helping others, he has the motivation to keep grinding.

October 9, 2025
Health Canada gives OK to therapy for patients 4 and older
October 8, 2025
People with Duchenne MD, other diseases have a place in shaping the future
October 7, 2025
Del-zota helps ambulatory, nonambulatory patients, trial data show
July 31, 2025
🧬 What Happened FDA Request: On July 18, the FDA informally asked Sarepta to voluntarily halt all U.S. shipments of its Duchenne DMD gene therapy, Elevidys—a move driven by safety concerns after three patient deaths due to acute liver failure. This included two fatalities in teenage Duchenne patients treated with Elevidys and a third in an adult patient from a different Sarepta gene therapy trial . Initial Pushback: Sarepta initially resisted, stating there were no new safety concerns for ambulatory patients (those who can walk), and maintained shipments for that group. They had previously paused shipments for non-ambulatory patients earlier in the year after two deaths . Reversal and Pause: On July 21–22, Sarepta reversed course and voluntarily paused all shipments in the U.S. by end of business Tuesday, July 22, 2025, to cooperate with the FDA, respond to inquiries, and complete a revised safety labeling for Elevidys . --- 📌 Why It Matters Safety Labeling Update: The pause allows Sarepta and the FDA time to add a stricter warning (including a new black-box liver-risk warning) and possibly implement a Risk Evaluation and Mitigation Strategy (REMS) for monitoring liver safety . Regulatory Relations: CEO Doug Ingram labeled the decision “painful,” but necessary for maintaining a collaborative and constructive relationship with the FDA . Market Impact: Sarepta’s stock plunged, falling as much as 8–5% on the news, and is down nearly 90% year to date. Analysts warn that the pause and black-box warning could severely affect Elevidys uptake and 50–61% of Sarepta's revenue . --- 🔍 What’s Next Duration of Pause: The pause could extend 3–6 months while safety data is reviewed and label changes are finalized . Potential Outcomes: Resumption: Elevidys could return under new safety protocols/label. A REMS program may be required . Market Withdrawal: Analysts caution on the possibility of permanent withdrawal if FDA's safety concerns aren't resolved . Pipeline Impact: FDA has also placed a clinical hold on Sarepta’s other gene therapy trials (including for Limb-Girdle Muscular Dystrophy) and revoked platform tech designation due to the shared AAVrh74 viral vector . --- ✅ In Summary Key Takeaway Details Pause in effect All U.S. Elevidys shipments halted since end of business July 22 Why Safety concerns after 3 liver-related deaths from same viral vector Next steps Label update, FDA review, possible REMS; uncertain pause duration Risks Potential permanent withdrawal, impact on revenue, and pipeline delays
June 20, 2025
This article originally appeared on www.statnews.com , written by Christine McSherry—a registered nurse and founder of the Jett Foundation—on June 18, 2025.
June 5, 2025
Aluminum is the third most abundant element in the Earth's crust and has a wide range of industrial and household applications. However, increasing evidence suggests that aluminum exposure may pose health risks, particularly concerning brain health and toxicity. In this article, we’ll explore what aluminum is, how it affects our bodies—especially the brain—and how it may contribute to neurodegenerative diseases like Alzheimer’s. We’ll also discuss sources of aluminum exposure, methods of testing for toxicity, and natural approaches to detoxification. 
June 4, 2025
We are incredibly honored to share that JAR of Hope has been named the 2025 Non-Profit of the Year by the Monmouth Regional Chamber of Commerce as part of their prestigious Beacon Awards . The Beacon Awards are designed to recognize organizations that exemplify outstanding community enrichment through service, leadership, and achievement. It means so much to us that both the MRCC membership and the community at large recognized the work we do and the mission we live by every day. This award is not just a recognition of our team’s efforts—it’s a reflection of the amazing community that supports us, believes in our cause, and stands with us in the fight to raise awareness, fund research, and bring hope to families affected by Duchenne Muscular Dystrophy.
April 22, 2025
As research into autism spectrum disorder (ASD) continues to evolve, one intriguing area of study is the role of the microbiome—the trillions of microorganisms living in our guts. Emerging evidence suggests that the health of our microbiome may have significant implications for children with autism, particularly in relation to gut disorders and neurological development. This blog explores the connection between the microbiome and autism, emphasizing the importance of detailed stool analyses, checking for parasites, and understanding the gut-brain relationship. What is the Microbiome? The microbiome refers to the vast community of bacteria, viruses, fungi, and other microorganisms that inhabit our digestive systems. These microorganisms play a crucial role in digestion, immunity, and even brain function. In children with autism, studies have indicated that there may be an imbalance in the microbiome, often referred to as dysbiosis. This condition can lead to gastrointestinal issues that are commonly reported in children with ASD, such as constipation, diarrhea, and abdominal pain.
April 10, 2025
A groundbreaking study published in Cell on January 23, 2020, has identified 102 genes associated with autism spectrum disorder (ASD), including 30 previously unlinked to the condition. Led by Joseph Buxbaum, director of the Seaver Autism Center for Research and Treatment at Mount Sinai, the research analyzed over 35,000 DNA samples, nearly 12,000 of which were from individuals with autism. The study leveraged advanced genetic sequencing technologies and data from the Autism Sequencing Consortium, an international collaboration of scientists sharing samples and data since 2010. By comparing genetic sequences from individuals with autism to their siblings and to unaffected individuals, the researchers identified both inherited mutations and spontaneous (de novo) genetic alterations that may contribute to ASD. Notably, the research distinguished genes more closely associated with autism from those linked to other neurodevelopmental disorders, such as intellectual and motor disabilities. This differentiation enhances our understanding of autism's molecular mechanisms and could inform the development of targeted treatments. Dr. Geraldine Dawson, director of the Center for Autism and Brain Development at Duke University, hailed the study as "one of the most important, comprehensive studies on the genetics of autism to date," emphasizing its role in elucidating the complex genetic landscape of ASD. ​ This research represents a significant step forward in autism genetics, offering hope for more personalized and effective interventions in the future. January 24, 2020 2:19 PM EST Time Magazine
April 10, 2025
A new study is shedding light on the potential of CBD to ease behavioral challenges in children with autism. Researchers in Israel found that cannabidiol (CBD), a non-psychoactive compound derived from cannabis, significantly improved symptoms like anxiety, aggression, and restlessness in kids on the spectrum. The peer-reviewed study, published in the journal Translational Psychiatry, followed 82 children and teens with autism who were treated with CBD-rich cannabis oil for six months. Results showed that many experienced meaningful improvements in behavior and social communication — with minimal side effects. Parents reported reduced irritability, fewer outbursts, and better sleep among participants. One mother shared that her nonverbal son began using more words and expressing emotions for the first time. While researchers emphasized that CBD isn’t a cure for autism, they believe it could be a safe and effective option to support children with challenging symptoms — especially when traditional treatments fall short. As interest in alternative therapies grows, this study adds to the growing body of research suggesting that CBD may offer a new avenue of hope for families navigating autism. Published April 8, 2025, 9:46 a.m. ET New York Post
More Posts